AstraZeneca and Vanderbilt University have signed a research collaboration agreement to identify candidate drugs aimed at treating psychosis and other neuropsychiatric symptoms associated with major brain diseases such as Alzheimer’s disease and schizophrenia.

There may be a biological basis for separate doll and dump truck aisles in the toy store.

Clinical pharmacologist Jens Titze, M.D., and colleagues have discovered that – in contrast to the prevailing dogma – human sodium levels fluctuate rhythmically with 7-day and monthly cycles.

Blocking a serotonin receptor may provide a novel therapy for heart valve disease.

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.

Even relatively low levels of in utero alcohol exposure impact fetal brain development, and the effects last into adulthood, study finds.

Archived tissue samples are yielding new disease biomarkers.